Upgrade to SI Premium - Free Trial

Ocugen (OCGN)

1.23 -0.03 (2.38%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26 *Est.)

Latest Headlines

Ocugen to Participate in Upcoming August Investor Conferences July 31, 2026 7:02 AM - StreetInsider Form DEFA14A Ocugen, Inc. July 30, 2026 4:37 PM - SEC Filing Form DEF 14A Ocugen, Inc. For: Sep 21 July 30, 2026 4:31 PM - SEC Filing Form SCHEDULE 13G Ocugen, Inc. Filed by: BlackRock, Inc. July 29, 2026 3:21 PM - SEC Filing FDA grants RMAT designation to Ocugen's OCU410 for dry AMD July 29, 2026 7:03 AM - StreetInsider Ocugen Announces that the U.S. Food and Drug Administration Has Granted OCU410 Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Geographic Atrophy, Secondary to Dry Age-Relat July 29, 2026 7:01 AM - StreetInsider Ocugen to Host Conference Call on Thursday, August 6 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2026 Financial Results July 28, 2026 4:01 PM - StreetInsider Form PRE 14A Ocugen, Inc. For: Sep 21 July 20, 2026 5:01 PM - SEC Filing Form 8-K Ocugen, Inc. For: Jul 13 July 13, 2026 8:31 AM - SEC Filing Ocugen signs MENA licensing deal for OCU400 gene therapy July 13, 2026 7:03 AM - StreetInsider Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa July 13, 2026 7:02 AM - StreetInsider Ocugen to Participate in Upcoming July Industry Conferences July 1, 2026 7:00 AM - StreetInsider Form 4 Ocugen, Inc. For: Jun 15 Filed by: Johnson-Greene Treerita Essalima June 17, 2026 4:14 PM - SEC Filing Form 4 Ocugen, Inc. For: Jun 11 Filed by: Kompella Uday June 15, 2026 4:35 PM - SEC Filing Form 4 Ocugen, Inc. For: Jun 11 Filed by: Chandrasekhar Satishchandran June 15, 2026 4:34 PM - SEC Filing Form 4 Ocugen, Inc. For: Jun 11 Filed by: Castillo Kirsten June 15, 2026 4:33 PM - SEC Filing Form 4 Ocugen, Inc. For: Jun 11 Filed by: Zhang Junge June 15, 2026 4:32 PM - SEC Filing Form 4 Ocugen, Inc. For: Jun 11 Filed by: Coleman Blaise June 15, 2026 4:31 PM - SEC Filing Form 8-K Ocugen, Inc. For: Jun 11 June 11, 2026 5:19 PM - SEC Filing Form 8-K Ocugen, Inc. For: May 29 June 3, 2026 4:32 PM - SEC Filing Ocugen to Participate in Upcoming June Investor and Industry Conferences June 2, 2026 7:03 AM - StreetInsider Ocugen, Inc. (OCGN) PT Lowered to $11 at Canaccord May 26, 2026 1:18 PM - StreetInsider Ocugen appoints new acting chief medical officer May 14, 2026 4:41 PM - StreetInsider Form 8-K Ocugen, Inc. For: May 08 May 14, 2026 4:32 PM - SEC Filing Form 8-K Ocugen, Inc. For: May 14 May 14, 2026 4:31 PM - SEC Filing Ocugen raises $130 million through convertible notes offering May 14, 2026 4:30 PM - StreetInsider Ocugen, Inc. Announces Closing for $130.0 Million of 6.75% Convertible Senior Notes May 14, 2026 4:30 PM - StreetInsider Ocugen to Participate in Upcoming May Scientific and Investor Conferences May 13, 2026 7:02 AM - Globe NewsWire Form 10-Q Ocugen, Inc. For: Mar 31 May 8, 2026 6:05 AM - SEC Filing Form 8-K Ocugen, Inc. For: May 07 May 7, 2026 4:15 PM - SEC Filing Form 8-K Ocugen, Inc. For: May 05 May 5, 2026 11:37 AM - SEC Filing Ocugen (OCGN) Misses Q1 EPS by 1c May 5, 2026 8:42 AM - StreetInsider Ocugen completes $115 million convertible notes offering to extend runway May 5, 2026 8:34 AM - StreetInsider Ocugen Provides Business Update with First Quarter 2026 Financial Results May 5, 2026 8:32 AM - Globe NewsWire Ocugen prices $115 million convertible notes at 6.75% interest May 5, 2026 8:12 AM - StreetInsider Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes May 5, 2026 8:12 AM - Globe NewsWire Form 8-K Ocugen, Inc. For: May 04 May 4, 2026 4:04 PM - SEC Filing Ocugen announces $115 million convertible notes offering May 4, 2026 4:02 PM - StreetInsider Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes May 4, 2026 4:01 PM - Globe NewsWire Full Article List